BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Affinium Pharmaceuticals

Affinium Pharmaceuticals is a specialty pharmaceutical company focused on the discovery, development and commercialization of novel anti-infective medicines. AFN-1252 utilizes a unique mechanism of action by directly inhibiting the function of the bacterial fatty acid synthesis (FAS) II pathway. Affinium’s FASII antibacterial programs constitute a new antibiotic franchise with the potential for multiple products targeting the FASII pathway. These programs include a broad base of long-term intellectual property: issued and pending composition of matter patents on potent orally available small molecule inhibitors of a new class of antibiotics with a unique mechanism of action, targeting an underexploited pathway and are not subject to resistance selection pressures caused by the use of existing broad spectrum antibiotics.


Contact Details:
1243 Islington Ave., Suite 600
Toronto
Ontario
M8X 1Y9
Canada
Tel:416-645-6613
Fax:416-646-1553
Email:oroberts@afnm.com
WWW:

www.afnm.com/




Loading...

Recent Publications by Affinium Pharmaceuticals:

Expression profiling of herpesvirus and vaccinia virus proteins using a high-throughput baculovirus screening system.
We have developed a high-throughput system for generating baculoviruses...
9th February, 2006
Affinium Pharmaceuticals, Toronto, Canada. J Proteome Res. 2005 Nov-Dec;4(6):2225-35.
DOI Direct Link
The structure of (3R)-hydroxyacyl-acyl carrier protein dehydratase (FabZ) from Pseudomonas aeruginosa.
Type II fatty acid biosynthesis systems are essential for membrane...
3rd February, 2005
Affinium Pharmaceuticals, Toronto, Ontario M5J 1V6, Canada. J Biol Chem. 2004 Dec 10;279(50):52593-602. Epub 2004 Sep 14.
DOI Direct Link
Reduced triclosan susceptibility in methicillin-resistant Staphylococcus epidermidis.
Triclosan MIC determination showed that recent Staphylococcus aureus...
25th May, 2004
Affinium Pharmaceuticals, Inc., Toronto, Ontario M5J 1V6, Canada. Antimicrob Agents Chemother. 2004 Apr;48(4):1397-9.
High-throughput protein crystallization.
High-throughput structural biology is a focus of a number of academic and...
10th February, 2004
Affinium Pharmaceuticals, 100 University Avenue, Ont., Toronto, Canada. J Struct Biol. 2003 Apr;142(1):154-61.
Data mining crystallization databases: knowledge-based approaches to optimize protein crystal screens.
Protein crystallization is a major bottleneck in protein X-ray...
23rd July, 2003
Affinium Pharmaceuticals Inc., Toronto, Ontario, Canada. Proteins. 2003 Jun 1;51(4):562-8.
DOI Direct Link

View more Affinium Pharmaceuticals research publications.

BioNews Results for Affinium Pharmaceuticals:

MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the Ameri
KOTA Territory News:  Jun 29 2008 2:17AM Matching: pharmaceuticals
Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals
NewsRX:  Jun 29 2008 2:15AM Matching: pharmaceuticals
MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the Ameri
TickerTech.com:  Jun 28 2008 2:12PM Matching: pharmaceuticals
MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the Ameri
Twin Cities Business Journal:  Jun 28 2008 6:23PM Matching: pharmaceuticals
MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the Ameri
San Francisco Business Times:  Jun 28 2008 2:45PM Matching: pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution

View more Affinium Pharmaceuticals news.

Affinium Pharmaceuticals Patents:

US Patent No.Title
7250424 Fab I inhibitors
6673941 Disubstituted imidazoles useful in the treatment of bacterial infections
6730684 Fab I inhibitors
6753172 FabI
6762201 Fab I inhibitors

View more Affinium Pharmaceuticals patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 989 times since April 2007, the link to the organisation's website has been followed 129 times

Recent Search Terms used to find this page: pharmaceuticals in toronto | Fate Therapeutics contacts | affinium private equity | f | affinium pharmaceuticals canada | Affinium COMPLETE PROFILE | @afnm.com | affinium pharmaceuticals in ontario canada | Affinium Pharmaceuticals Fab | affinium pharmaceutical toronto | .

Search for more companies in Toronto

Search for more companies in Ontario



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Affinium Pharmaceuticals
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.